Polatuzumab Vedotin in Combination with Bendamustine Plus Rituximab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Our Experience

Darcin T., Yigenoglu T. N., Sahin D., Bakirtas M., BAŞCI S., Merdin A., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.19, 2019 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 19
  • Publication Date: 2019
  • Doi Number: 10.1016/j.clml.2019.07.155
  • Journal Name: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: polatuzumab vedotin, relapsed/refractory NHL, combined chemotherapy, ABCL, aggressive B-cell lymphoma, case
  • Dokuz Eylül University Affiliated: No